Atrium Therapeutics, Inc. Common Stock (NASDAQ: RNA) last traded at $8.40, up 1.69% on the session. The quote above updates while this page is open; the figures below are drawn from Atrium Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Atrium Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RNA. Its market capitalisation is $143.69 million.
Valuation measures for Atrium Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $143.69M |
|---|---|
| Enterprise value | $137.29M |
| Price / book | 0.67 |
| Beta | 1.11 |
Trailing-twelve-month figures tagged in Atrium Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Cash |
|---|
| $72.33M |
Range and volume for RNA over the past 52 weeks.
| 52-week high | $16.77 |
|---|---|
| 52-week low | $7.63 |
| Volume | 208.3K |
| Average volume | 258.6K |
| Previous close | $8.26 |
Invest a chosen dollar amount in Atrium Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RNA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.